The antidysrhythmic, haemodynamic and metabolic effects of a new prospective antianginal and antidysrhythmic agent, N-(3,3-diphenylpropyl)-a-methyl-/B-cyclohexylethylamine hydrochloride (MG 8926), have been compared with the chemically related substance, prenylamine, in anaesthetized greyhounds and guinea-pigs. 2 When given intravenously 20 min beforehand, both MG 8926 and prenylamine (5 mg/kg) significantly suppressed the early dysrhythmias induced by coronary artery ligation in anaesthetized greyhounds. At a dose of 1 mg/kg, MG 8926 also protected anaesthetized guinea-pigs from dysrhythmias induced by ouabain infusions. 3 In dogs pretreated with MG 8926, metabolic changes indicative of myocardial ischaemia (increased Pco2 and potassium efflux, decreased oxygen content and pH) were less marked than those occurring in control animals. 4 Evidence was obtained that MG 8926, when given either before or after coronary occlusion, was capable of decreasing the severity of myocardial ischaemia as assessed by ST-segment changes in epicardial electrocardiograms.
Introduction
Methods MG 8926 is a recently synthesized secondary amine structurally related to the antianginal drug prenylamine. It increases coronary flow in the isolated guinea-pig heart and partially inhibits pitressininduced ST-segment changes in anaesthetized rats (M. Carissimi, personal communication 1975) . In preliminary experiments we found that it also elevated coronary blood flow in the anaesthetized greyhound and reduced the incidence of cardiac dysrhythmias which result from acute ligation of the anterior descending branch of the left coronary artery in this experimental model. This paper describes the detailed haemodynamic effects of this compound and, where appropriate, these effects are compared with those of prenylamine. 
A naesthetized greyhounds
Experiments were carried out on 27 greyhounds of either sex weighing between 23 and 31 kg. Anaesthesia was induced by intravenous administration of sodium thiopentone (20 mg/kg). After endotracheal intubation, respiration was applied from a positive-pressure ventilation pump (25 strokes/min), with 100% 02 containing 0.5-1.0% trichlorethylene. The tidal volume of the pump was adjusted to maintain an arterial Pco2 of 35-40 mmHg (1 mmHg = 1.33 mbar). Reflex movements were prevented by the intermittent intramuscular administration of suxamethonium chloride (100 mg).
In six of the dogs, myocardial nutritive blood flow was measured without thoracotomy by the radioactive xenon clearance method (Ledingham, McBride, Parratt & Vance, 1970; Marshall & Parratt, 1976) . In order to measure myocardial 02 availability and consumption, a catheter was positioned under fluoroscopic control in the coronary sinus and blood samples were taken, without exposure to air, from this catheter and, simultaneously, from a catheter in the descending aorta. The blood was analysed for Po2, Pco2 and pH as previously described (Marshall, Parratt & Ledingham, 1974) .
In another group of 12 dogs, catheters were placed, under fluoroscopic control, in the descending aorta (via the right femoral artery), the right atrium (via the right saphenous vein), the pulmonary artery and the coronary sinus (both via the left external jugular vein). A catheter-tip transducer (Millar Instruments, Inc., Houston, Texas) was inserted into the lumen of the left ventricle (via the left carotid artery in the neck) for the measurement of left ventricular pressure and also dP/dt (using an Elema-Schonander differentiating circuit). The frequency response of this transducer system is flat to 200 Hz. Records of left ventricular pressure at high gain allowed accurate assessments to be made of left ventricular end-diastolic pressure (LVEDP) .
Cardiac output was measured either by dye-dilution, indocyanine green (2.5 mg) being injected as a bolus into the right atrium and blood withdrawn at a constant rate through a Waters densitometer, or by thermo-dilution, as described by Douglas, McDonald, Milligan, Mellon & Ledingham (1975) . All cardiac output determinations were made in duplicate. There is a good correlation between cardiac output measurements made by these two methods (Douglas et al., 1975) .
In the remaining dogs, the heart was exposed through a left thoracotomy and the pericardium overlying the anterolateral aspect of the heart was incised. Blood flow in the circumflex branch of the left coronary artery was measured with a Nycotron 372 electromagnetic flow meter using a calibrated probe of 1.5-2.5 mm diameter. The anterior descending branch of the left coronary artery (LAD), at a point distal to the septal artery branch, was prepared for ligation with minimum dissection. A major branch of the main vein adjacent to the artery (the anterior coronary vein) was catheterized using tIe Seldinger technique with a 10 cm Longdwel teflon catheter (size 20G) . This local coronary vein catheter was not tied in position and was manipulated until its tip lay well into the region of the myocardium which was to be made ischaemic. It has been shown that such a coronary vein catheter, after coronary artery ligation, drains blood predominantly from the ischaemic region (Fisher, Heimbach, Ledingham, Marshall & Parratt, 1973; .
Blood samples were taken, without exposure to air, at regular intervals and were analysed for°2 and CO2 tensions, 02 content and pH, as outlined by Ledingham et al. (1970) and cardiac work, peripheral vascular resistance, and whole body 02 consumption as described by Ledingham, Parratt, Smith & Vance (1971) .
In four additional dogs, the effects of prophylactically administered MG 8926 on ischaemiainduced epicardial ST-segment changes were investigated. These dogs were subjected to thoracotomy and a nylon snare placed around the LAD. Nine silver electrodes embedded in a triangular sheet of rubber were sutured on to the anterior surface of the left ventricle; epicardial electrocardiograms could be recorded simultaneously from any three sites through a rapid switching circuit. After control tracings from each site had been obtained the LAD 
Anaesthetized guinea-pigs
The preparation used was essentially that described by Dohadwalla, Freedberg & Vaughan Williams (1969) . Female guinea-pigs weighing between 300-400 g were anaesthetized with urethane (1.6 g/kg, i.p. Isolated electrically-driven atrial muscle ofguinea-pig Guinea-pigs weighing between 200-310 g were killed by stunning and exsanguination and the left atrium quickly excised and placed in a 10 ml organ bath containing Krebs-Henseleit solution (g/I: NaCl 6.9, KCI 0.35, NaHCO3 2.1, KH2PO4 0.16, MgSO4 0.29, CaCl2 0.56, glucose 2.0) bubbled with carbogen. The left atrial preparations were stimulated via a platinum electrode with supra-threshold (3-6 V) square wave pulses, of 5 ms duration and at 2 Hz. Contractions were measured by attaching the free end of the atria by means of a cotton thread to a strain gauge transducer (Ether UF 1) and were recorded on a Devices M2 recorder.
To measure the effective refractory period of left atria, the stimulation was steadily increased until the atria could no longer follow each stimulus. This maximum driving frequency (MDF) is inversely related to effective refractory period (Ellis, 1956 and, since heart rate remained constant, the increase in cardiac output could be attributed to an increase in stroke volume. Myocardial nutritional blood flow (as assessed by xenon clearance) was consistently elevated by MG 8926 (2.5 and 5.0 mg/kg) and, since systemic blood pressure was reduced, this indicates a reduction in coronary vascular resistance of between 30-55%. Since coronary sinus P02 rose (and therefore myocardial°2 extraction fell) there was no change in myocardial°2 consumption, and thus the ratio of available°2 to consumed°2 was increased by MG 8926 (from 2.7 + 0.6 to 4.0 + 0.6; P < 0.05). All these haemodynamic effects of MG 8926 were relatively transient and all parameters returned to control values within 10-15 min of injection.
A comparison of the haemodynamic effects of intravenously administered MG 8926 and prenylamine lactate (S mg/kg) in the open chest anaesthetized greyhound After the intravenous injection of MG 8926 (5 mg/kg; 6 dogs) there occurred an immediate transient decrease in blood pressure (mean decrease in diastolic pressure of 44 + 7 mmHg). Neither heart rate (mean change + 8 ± 14 beats/min) nor left ventricular dP/dt max (mean change + 80+ 140 mmHg/s) was affected by the drug. In the two experiments in which they were measured, cardiac output and myocardial blood flow were considerably but transiently increased (by 21% and by 68% respectively) and there was a marked reduction in myocardial 02 extraction (from 41 + 6 to 21 + 5%; P < 0.05) 3 min after injection. The haemodynamic effects of MG 8926 in the open chest animal were, like those in the closed chest, transient so that 10 min after drug administration there were no significant changes in blood pressure (185 + 12 mmHg systolic and 128±6 mmHg diastolic before the drug and 187+12 and 133+6 mmHg after), heart rate (187 + 12 to 169 ± 7), left ventricular dP/dt max (3750+ 420 to 3580+ 40 mmHg/s), LVEDP (8± 1 to 9 + 1 mmHg), cardiac output (4.1 + 0.4 to 4.0 + 0.4 1/min), external cardiac work (4.5 ± 0.5 to 4.9 + 0.6 kgm/min), myocardial 02 extraction (41 + 6 to 37 + 6%), peripheral vascular resistance (37 ± 2 to 38 + 2 arbitrary units) and whole body 02 consumption (134 + 15 to 114 + 10 ml/minute).
Prenylamine lactate (5 mg/kg; 6 dogs) also caused an immediate fall in blood pressure (a reduction of 46 + 10 mmHg in diastolic pressure) but in contrast to MG 8926, this was accompanied by transient but significant increases in heart rate (from 168 + 11 to 202 + 7 beats/min; P <0.05) and in left ventricular dP/dt max (mean increase 667+ 80 mmHg/second). Pulmonary artery pressure was initially increased from 18 + 3 mmHg systolic, (9 ± 1 diastolic) to 24 + 4 mmHg systolic (13 ± 1 mmHg diastolic) (P <0.05).
Like MG 8926, prenylamine lactate also caused a transient increase in cardiac output (4.3 ± 0.2 to 5.5 + 0.2 litres/min, P< 0.05) and a marked decrease in myocardial 02 extraction (38 ± 5 to 22 + 3%; P < 0.05). As with MG 8926, all parameters had returned to control levels 10 min after the injection of prenylamine.
A constant finding with prenylamine was the production of dysrhythmias on injection. These dysrhythmias were ventricular in origin and lasted 5-10 minutes. In contrast, MG 8926 altered cardiac rhythm, and that transiently, on only one occasion. Table 4 , and the effects on lactate extraction illustrated in Figure 1 . Clearly, neither drug significantly modified these metabolic consequences of coronary artery ligation, although the changes in coronary vein 02 content, Pco2 and pH were rather less than those seen in the control animals (Table 4) .
Another metabolic change induced by coronary ligation is loss of potassium from ischaemic cardiac cells (Thomas, Shulman & Opie, 1970; Marshall & Parratt, 1975) . In a series of untreated dogs, coronary vein potassium rose significantly from 3.5 + 0.3 (preligation) to 4.4 + 0.2 mEq/litre, 30 min after ligation, although arterial and coronary sinus levels remained unchanged. In the dogs pretreated with MG 8926 the increase in coronary vein potassium (3.4 + 0.2 to 3.9 + 0.3 mEq/litre respectively) was significantly less than in the control animals. Similar results were obtained in the prenylamine-treated animals; coronary vein potassium rising from 3.0 + 0.2 to 3.4 + 0.2 mEq/litre (P < 0.05). ligation. The drug caused an immediate, but transient, fall in blood pressure (mean diastolic change 63+4 mmHg) and increased cardiac output (mean 34%) and both coronary sinus P02 (29±3 to 56+7 mmHg; P <0.05) and coronary vein Po2 (30 ± 1 to 49+5 Values are mean ± s.e.; n = 6. *P<0.05.
mmHg; P <0.05). Although all these parameters had returned to control levels 10 min after injection, there were at this time significant decreases in heart rate and dP/dt max and increases in LVEDP (Table 5) The observation, in dogs treated with MG 8926, that the metabolic changes following coronary artery ligation were less marked than those seen in control animals prompted us to examine the effects of the drug on the extent and severity of myocardial ischaemia as assessed by epicardial electrocardiograms. The effects of prophylactically administered MG 8926 (5.0 mg/kg) on ST-segment elevation after acute occlusion of the LAD are shown in Figure 2 . It is clear that, at this dose, MG 8926 decreases ST-segment elevation at all times after occlusion. In addition, the number of sites showing more than 2 mV ST-segment elevation, 3 min after occlusion, was significantly reduced (from 4.5 ± 0.6 to 2.5 + 0.6; P <0.05).
The effects of MG 8926 (5 mg/kg; five experiments) were also examined on ST-segment elevation in dogs in which the LAD had been ligated 1 to 2 h previously. The mean ST-segment elevation from all the seven sites varied in individual dogs (from 1.6 + 0.9 to 5.1 + 1.9 mV) but remained constant in each preparation over the 30 min preceding the injection of MG 8926. Particular attention was paid to the effect of MG 8926 on the border areas between normal and clearly ischaemic regions (usually leads 2, 3 and 4). In six such border sites, MG 8926 reduced mean STsegment elevation from 4.3 + 0.3 to 2.4 + 0.6 mV (P < 0.05). This decrease in ST-segment elevation was still evident 20-30 min after administration of MG 8926. The results from one of these experiments are illustrated in Figure 3 .
The effects ofMG 8926 andprenylamine on ouabaininduced dysrhythmias in the anaesthetized guinea-pig
The concentrations of ouabain required to produce (a) the first signs of rhythm abnormality (unequal R-R intervals), (b) ventricular extrasystoles, (c) sustained ventricular tachycardia, (d) ventricular fibrillation and (e) cardiac arrest in animals treated with either saline, MG 8926 (1 mg/kg) or prenylamine (1 mg/kg) are shown in Table 6 . Injection of saline (<0.5 ml) had no significant effect on heart rate (320± 10 to 324 ± 9 beats/min, 30 s after injection). All control animals (saline-treated) developed ventricular fibrillation compared with only half of those treated with either MG 8926 or prenylamine. In addition MG 8926
(1 mg/kg) significantly increased the amount of ouabain necessary to induce ventricular tachycardia, ventricular fibrillation and cardiac arrest (Table 6 ). This dose of MG 8926 caused a significant decrease in Both MG 8926 and prenylamine significantly decreased the maximum driving frequency of atrial muscle. The magnitude of this effect was critically dependent on the time the drug was in contact with the tissue (Figure 4 ). (Nielsen & Owman, 1967) , or by the application of various chemicals (Lindner, 1963; Szekeres & Papp, 1971) , there is no information available on the efficacy of prenylamine (or compounds, like MG 8926, of similar structure) in suppressing the early dysrhythmias that occur in the acute phase of experimental myocardial infarction. This information is of some importance since it is known that 61% of electrical deaths arising from myocardial infarction among patients younger than 65 occur within one hour of onset (Gordon & Kannel, 1971 (Schone & Lindner, 1962) . This effectively reduces cardiac sympathetic drive which has been implicated in the genesis of early arrhythmias induced either by coronary ligation (Harris, Estandia & Tillotson, 1951; Harris & Bisteni, 1955; Shanks & Dunlop, 1967) or by infusion of cardiac glycosides (Dohadwalla et al., 1969) . Secondly, prenylamine causes direct effects on various phases of the cardiac action potential. Thus it has been shown that prenylamine slows the maximum rate of rise (phase 0), increases the threshold potential, increases refractory period and depresses pacemaker activity (Lindner, 1963) . These direct effects of prenylamine are now thought to be due to depression of the inward sodium and/or calcium currents involved in cell depolarization processes (Haas, Kern, Benninger & Einwachter, 1975 (Peiper, Griebel & Wende, 1971) . The transient but considerable increases in cardiac output caused by both drugs may also be due to an effect on cardiac calcium flux.
It has been demonstrated in anaesthetized cats, and rat isolated perfused hearts, that prenylamine is capable of releasing substantial amounts of noradrenaline (Grobecker, Palm & Holtz, 1968) . In this present investigation, further circumstantial evidence that prenylamine causes noradrenaline release is available from the fact that, immediately on injection, it increased heart rate and myocardial contractility (as measured by dP/dt max) and evoked marked ventricular ectopic activity. Interestingly, MG 8926 did not cause positive chronotropic or inotropic effects in vivo, nor did it induce ectopic activity.
On guinea-pig isolated atrial muscle, both compounds (2-30 gM) decreased developed tension, in a dose-dependent manner. This was usually preceded by a transient positive inotropic effect. These results confirm previous findings with prenylamine (Fleckenstein, Kammermeier, Doring & Freund, 1967; Lindner, 1969) . The view has recently been presented that this inotropic effect of prenylamine may be due to an inhibition of active calcium transport within the cell, leading to transient increases in available calcium (Haas et al., 1975 (Smith, Singh, Nisbet & Norris, 1975; Wende, Bleifeld, Meyer & Stiihlen, 1975) . In the present investigation there was some evidence that MG 8926 (administered either before or after occlusion) was capable of favourably influencing the balance between myocardial°2 supply and demand (as assessed by epicardial ST-segment changes) especially in border areas surrounding the developing infarct. The mechanism behind this reduction in ischaemia seen after MG 8926 may involve both bradycardia and a reduction in the resistance to blood flow in the ischaemic zone. It has certainly been established that a decrease in heart rate is important for the beneficial effects of,B-adrenoceptor antagonists in myocardial ischaemia (Gross & Winbury, 1973; Marshall & Parratt, 1976) and that propranolol decreases the degree of ischaemia-induced ST-segment elevation largely by slowing heart rate (Wendt et al., 1974) . In this study it was observed that MG 8926 only reduced heart rate when administered after coronary artery occlusion, a fact which may be related to the effects of the drug on the increased sympathoadrenal outflow produced by myocardial ischaemia (Staszewska-Barczak & Ceremuzynski, 1968) .
